Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study

BACKGROUND: Recent studies reported that sodium glucose cotransporter 2 (SGLT2) inhibitors can potentially reduce the risk of cardiovascular mortality in patients with type 2 diabetes mellitus (T2DM). However, there is little or no information on the therapeutic effects of SGLT2 inhibitors on the pr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cardiovasc Diabetol
Autori principali: Shigiyama, Fumika, Kumashiro, Naoki, Miyagi, Masahiko, Ikehara, Kayoko, Kanda, Eiichiro, Uchino, Hiroshi, Hirose, Takahisa
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5500953/
https://ncbi.nlm.nih.gov/pubmed/28683796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-017-0564-0
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi